Skip to main content
Fig. 11 | BMC Cancer

Fig. 11

From: Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma

Fig. 11

Genetic mutations in S100As and their association with OS and PFS of PDAC patients (cBioPortal). High mutation rate (31%) of S100As was observed in PDAC patients. S100A14, S100A10 and S100A16 ranked the highest three genes of genetic alterations, and their mutation rates were 16, 14 and 13%, respectively. a, S100As expression and mutation analysis in PDAC. b-c, genetic alterations in S100As were associated with shorter OS and PFS of PDAC patients

Back to article page